Stockreport

Trevi Therapeutics Announces Second Quarter 2019 Financial Results and Recent Business Developments

Trevi Therapeutics, Inc.  (TRVI) 
PDF NEW HAVEN, Conn., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and [Read more]